Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?

Antzeko izenburuak

• Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients
  nork: Ryoo, Hyunsoo, et al.
  Argitaratua: (2020)
• The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
  nork: Song, Wan, et al.
  Argitaratua: (2019)
• Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance
  nork: Yu, Jiwoong, et al.
  Argitaratua: (2021)
• Utility of multiple core biopsies during transperineal template-guided mapping biopsy for patients with large prostates and PI-RADS 1–2 on multiparametric magnetic resonance imaging
  nork: Chung Un Lee, et al.
  Argitaratua: (2022-03-01)
• Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL)
  nork: Chung, Jae Hoon, et al.
  Argitaratua: (2020)